Importantly, blockade of Cd96 using an anti-Cd96 antibody or gene knockout improved the function of NK cells in mice.748 After treatment with trastuzumab, NK cells were reported to be activated, expressing the co-stimulatory CD137 receptor in the peripheral blood of women with HER2-expressing breast cancer. Here, CD96 is linked to breast cancer.